Evidence map›Paper›PMID 40212998›Full record

ArticleSmall science2024

Nano-bio-interface: Unleashing the Potential of Noble Nanometals.

Peng Guo, Yiyun Wang, Hongbo Cui, Xiang Yao, Guijian Guan, Ming-Yong Han

Abstract read
In one paragraph

Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Gold Nanoparticles Guided by Self-Assembling Peptides: From Sequence to Superstructure.Chembiochem : a European journal of chemical biology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peng GuoInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.
Yiyun WangInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.
Hongbo CuiInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.
Xiang YaoInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.
Guijian GuanInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.
Ming-Yong HanInstitute of Molecular Plus Tianjin University 92 Weijin Road Tianjin 300072 China.ORCID https://orcid.org/0000-0002-7519-6779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered noble metal nanomaterials (NMN) possess adjustable optical, electrical, and biocompatible properties that make them excellent tools for probing the nano-bio-interface. Understanding their interactions with biomolecules, cells, and tissues at the nano-bio-interface is crucial in designing these nanomaterials for biomedical applications. This review summarizes the structure, properties, synthesis, and passivation methods of noble metal nanoparticles, as well as the construction strategy and detection technology of the nano-bio-interface to provide important information about their uptake, distribution, metabolism, and degradation in vivo and in vitro. The related action mechanisms include the kinetic and thermodynamic processes of the nano-bio-interface, the driving forces for its formation, and the chemical reactions at the nano-bio-interface. By exploring the action mechanism of the nano-bio-interface, the antibacterial properties and cytotoxicity of NMN could be better understood, and open up more extensive biological applications. Finally, the future trends of NMNs in the biological field and the challenges encountered in realizing these technologies are discussed.

Indexed as

bioapplicationsfunctionalitynano‐bio‐interfacenoble nanomaterials

Identifiers

PMID40212998
PMCPMC11935218

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.